Granulocyte colony-stimulating factor (G-CSF) dependent hematopoiesis with monosomy 7 in a patient with severe aplastic anemia after ATG/CsA/G-CSF combined therapy

International Journal of Hematology

Volumn 68, Issue 2, 1998, Pages 203-211

  Nishimura, Manabu ^a   Yamada, Tetsuya ^a   Andoh, Toshihiko ^a   Tao, Tsuyoshi ^a   Emoto, Masahiro ^a   Ohji, Toshiaki ^a   Matsuda, Kazuyuki ^a   Kameda, Naoko ^a   Satoh, Yutaka ^a   Matsutani, Akira ^a   Azuno, Yoichi ^b   Oka, Yoshitomo ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Int Med Div Hematol 1315 4 O   (Japan)

Author keywords

Aplastic anemia; Granulocyte colony stimulating factor; Monosomy 7

Indexed keywords

ANTIBIOTIC AGENT; CYCLOSPORIN A; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ADULT; APLASTIC ANEMIA; ARTICLE; AUTOIMMUNE HEPATITIS; BONE MARROW BIOPSY; CASE REPORT; CLONOGENESIS; DISEASE COURSE; ERYTHROPOIESIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEGAKARYOPOIESIS; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; MYELOPOIESIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; PRIORITY JOURNAL;

EID: 0031787650     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(98)00047-4     Document Type: Article

References (21)

1. Kojima S, Tsuchida M, Matsuyama T Myelodysplasia and leukemia after treatment of aplastic anaemia with G-CSF. New Engl J Med. 326:1992;1294-1295.
2. Ohara A, Kojima S, Hamajima N et al. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood. 90:1997;1009-1013.
3. De Planque MM, Kluin-Nelemans HC, Van Krieken HJ et al. Evolution of acquired severe aplastic anemia to myelodysplasia and subsequent leukemia in adults. Br J Haematol. 70:1988;55-62.
4. Baer MR, Bernstein SH, Brunetto VL et al. Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia. Blood. 87:1996;1484-1494.
5. Tichelli A, Gratwohl A, Nissen C et al. Late clonal complications in severe aplastic anemia. Leuk Lymph. 12:1994;167-175.
6. Imashuku S, Hibi S, Morimoto Y et al. Myelodysplasia and acute myeloid leukemia in cases of aplastic anemia and congenital neutropenia following G-CSF treatment. Br J Haematol. 89:1995;188-190.
7. Smith OP, Reeves BR, Kempski HM et al. Kostmann's disease, recombinant HuG-CSF, monosomy 7 and MDS/AML. Br J Haematol. 91:1995;150-153.
8. Weinblatt ME, Scimeca P, James-Herry A et al. Transformation of congenital neutropenia into monosomy 7 and acute nonlymphoblastic leukemia in a child treated with granulocyte colony-stimulating factor. J Pediatr. 126:1995;263-265.
9. Shekhter-Levin S, Penchansky L, Wollman MR et al. An abnormal clone with monosomy 7 and trisomy 21 in the bone marrow of a child with congenital agranulocytosis (Kostmann disease) treated with granulocyte colony-stimulating factor. Cancer Genet Cytogenet. 84:1995;99-104.
10. Kalra R, Dale D, Freedman M et al. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood. 86:1995;4579-4586.
11. Imashuku S, Hibi S, Nakajima F et al. A review of 125 cases to determine the risk of myelodysplasia and leukemia in pediatric neutropenic patients after treatment with recombinant human granulocyte colony-stimulating factor. Blood. 84:1994;2380-2381.
12. Hashino S, Imamura M, Tanaka J et al. Transformation of severe aplastic anemia into acute myeloblastic leukemia with monosomy 7. Ann Hematol. 72:1996;337-339.
13. Yamato H, Yamada K, Koike T et al. Complete remission achieved by low-dose Ara-C, aclarubicin and rhG-CSF (CAG) therapy in acute non-lymphocytic leukemia with monosomy 7 occurring after severe aplastic anemia. Jap J Clin Hematol. 36:1995;128-133.
14. Kaito K, Otsubo H, Ogasawara Y et al. RAEB in T with monosomy 7 after treatment of severe aplastic anemia with long term G-CSF. Jap J Clin Hematol. 36:1995;365-370.
15. Luna-Fineman S, Shannon KM, Lange BJ et al. Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood. 85:1995;1985-1999.
16. Kalra R, Paderanga DC, Olson K et al. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21 ras. Blood. 84:1994;3435-3439.
17. Yunis JJ, Rydell RE, Oken MM et al. Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood. 67:1986;1721-1730.
18. Jacobs A Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. J Clin Pathol. 38:1985;1201-1217.
19. Masumoto A, Ohbayashi Y, Kawada H et al. Cytarabine ocfosulfate upregulates the effects of granulocyte colony-stimulating factor in myelodysplastic syndrome with monosomy 7. Jpn J Clin Hematol. 35:1994;603-608.
20. Paquette RL, Tebyani N, Frane M et al. Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood. 85:1995;283-290.
21. Ohkusa A, Sugahara Y, Imai Y et al. Evolution of severe aplastic anemia into myelodysplasia with monosomy 7 after granulocyte colony-stimulating factor, erythropoietin and high-dose methylprednisolone combination therapy. Int Med. 34:1995;892-895.